FDA Inspection 1227760 — Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. — FEI 3017199602

The FDA completed an inspection of Rocket Pharmaceuticals, Inc. on Jan 25, 2024 in Cranbury, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 25, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Cranbury, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
741121 CFR 312.53(c)(1)Investigator statement (FDA 1572)
748221 CFR 312.50General responsibilities of sponsors

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.